查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1998681

2026 年至 2035 年足踝醫療設備市場的商業機會、成長要素、產業趨勢與預測。

Foot and Ankle Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 210 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，全球足踝醫療設備市場價值將達到 53 億美元，並預計以 6.9% 的複合年成長率成長，到 2035 年達到 104 億美元。

足踝器材市場-IMG1

整形外科疾病發生率上升、創傷病例增加以及足踝醫療設備技術的進步是推動該市場成長的主要因素。糖尿病患者數量及其相關足部併發症的增加，加上患者客製化植入和微創手術的創新發展，正在加速市場需求。老化和生活方式相關的風險因素也加劇了足踝疾病的發生。此外，全球交通事故和高能量創傷病例的增加，也推動了對用於治療骨折、韌帶斷裂、脫位和其他下肢損傷的醫療設備的需求。包括材料科學和醫療設備工程在內的技術創新，正在顯著改善患者的治療效果，進一步促進市場擴張。

市場範圍
開始年份 2025
預測期 2026-2035
上市時的市場規模 53億美元
預計金額 104億美元
複合年成長率 6.9%

預計到2025年，整形外科植入和醫療設備領域將佔據70.3%的市場。這一成長主要得益於3D列印整形外科植入的應用以及創傷、畸形矯正和退化性關節疾病手術量的激增。骨科植入仍是治療足踝疾病（包括創傷固定、關節重組和畸形矯正）的主要選擇。下肢骨折、糖尿病足併發症、老齡化相關性肌肉骨骼退化以及運動傷害的發生率不斷上升，正在推動全球整形外科植入物的需求。

預計到2025年，門診手術中心（ASC）市場規模將達到13億美元，並在2026年至2035年間以6.7%的複合年成長率成長。門診手術中心受益於整形外科和微創手術轉移到門診的全球趨勢。麻醉、疼痛管理和手術器械的進步使得門診手術中心能夠安全地進行拇趾滑液囊炎矯正、韌帶重組和內固定等手術，推動了市場成長。

美國足踝醫療設備市場預計到2025年將達到26億美元。這一成長主要得益於個人化植入的研發、完善的醫療基礎設施、大量的手術量、全面的醫保報銷機制、積極的研發投入以及便捷的整形外科專家資源。美國在創新方面也處於領先地位，諸如全踝關節置換系統、先進的固定螺絲、人工軟骨植入和外固定架等新技術，通常在進入全球市場之前，先在國內進行臨床檢驗。

目錄

第1章：調查方法

  • 研究途徑
  • 品質改進計劃
    • GMI人工智慧政策及對資料完整性的承諾
      • 資訊來源一致性通訊協定
  • 調查過程和可靠性評分
    • 研究路徑的組成部分
    • 評分組成部分
  • 數據收集
    • 主要來源部分列表
  • 資料探勘資訊來源
    • 付費資訊來源
      • 區域資訊來源
  • 基本估算和計算方法
    • 基準年的計算
  • 預測模型
    • 量化市場影響分析
      • 生長參數對預測的數學影響
  • 關於調查透明度的補充信息
    • 資訊來源歸屬框架
    • 品質保證指標
    • 對信任的承諾

第2章執行摘要

第3章業界考察

  • 生態系分析
  • 影響產業的因素
    • 促進因素
      • 整形外科疾病盛行率增加
      • 創傷和交通事故發生率增加
      • 足踝裝置的技術進步
    • 產業潛在風險與挑戰
      • 足部及踝部醫療設備高成本
      • 熟練醫護人員短缺
    • 機會
      • 數位健康與智慧矯正器具的融合
  • 成長潛力分析
  • 監理情勢
    • 北美洲
      • 美國
      • 加拿大
    • 歐洲
    • 亞太地區
  • 科技與創新趨勢
    • 當前技術趨勢
    • 新興技術
  • 未來市場趨勢
  • 救贖方案
    • 北美洲
    • 歐洲
    • 亞太地區
  • 消費行為分析
  • 環形天線固定器競爭格局分析（依公司分類）
  • 六足機器人類別及技術差異化
  • 產品特定價格趨勢
  • 差距分析
  • 波特五力分析
  • PESTEL 分析

第4章 競爭情勢

  • 介紹
    • 打擊者公司
    • 德普合成（強生公司）
    • Earthrex有限公司
  • 企業矩陣分析
  • 企業市佔率分析
    • 世界
    • 北美洲
    • 歐洲
    • 亞太地區
  • 主要市場公司的競爭分析
  • 競爭定位矩陣
  • 主要進展
    • 併購
    • 夥伴關係與合作
    • 新產品發布
    • 業務拓展計劃

第5章 市場估價與預測：依產品分類，2022-2035年

  • 整形外科植入和醫療設備
    • 關節移植
      • 足關節移植
      • 其他關節移植
    • 固定裝置
      • 內固定裝置
        • 盤子
        • 擰緊
        • 固定釘
        • 其他內部固定裝置
      • 外固定裝置
        • 環形固定系統
        • 銷釘桿系統
        • 六足系統
        • 其他外固定裝置
    • 軟組織整形外科器械
  • 矯正器具和支撐裝置
    • 軟性矯正器具和支撐器具
    • 剛性矯正器具和支撐裝置
    • 鉸鍊式矯正器具和支撐器具
  • 義肢

第6章 市場估計與預測：依應用領域分類，2022-2035年

  • 創傷
  • 錘狀趾
  • 骨關節炎
  • 類風濕性關節炎
  • 神經系統疾病
  • 骨質疏鬆症
  • 其他用途

第7章 市場估計與預測：依最終用途分類，2022-2035年

  • 醫院
  • 門診手術中心
  • 整形外科診所
  • 其他最終用戶

第8章 市場估計與預測：依地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第9章：公司簡介

  • aap implantate AG
  • Acumed LLC
  • Arthrex, Inc.
  • CONMED Corporation
  • DePuy Synthes（Johnson & Johnson）
  • Embla Medical Corporation
  • Enovis Corporation
  • Fillauer LLC
  • Medartis
  • Orthofix Medical Inc.
  • Ottobock SE & Co KGaA
  • Smith & Nephew plc
  • Stryker Corporation
  • VILEX, LLC
  • Zimmer Biomet Holdings, Inc.
簡介目錄
Product Code: 3445

The Global Foot and Ankle Devices Market was valued at USD 5.3 billion in 2025 and is estimated to grow at a CAGR of 6.9% to reach USD 10.4 billion by 2035.

Foot and Ankle Devices Market - IMG1

The market's growth is driven by the rising prevalence of orthopedic disorders, an increasing number of trauma cases, and advancements in foot and ankle device technologies. A growing diabetic population with related foot complications, coupled with the development of patient-specific implants and minimally invasive surgical innovations, is accelerating demand. Aging populations and lifestyle-related risk factors are also contributing to the rise in foot and ankle disorders. Furthermore, the global increase in road traffic accidents and high-impact trauma cases is boosting the need for devices that manage fractures, ligament tears, dislocations, and other lower extremity injuries. Technological innovation, including improvements in material science and device engineering, has significantly enhanced patient outcomes, further supporting market expansion.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$5.3 Billion
Forecast Value$10.4 Billion
CAGR6.9%

The orthopedic implants and devices segment held 70.3% share in 2025. Growth is being fueled by the adoption of 3D-printed orthopedic implants and the high procedural volume for trauma, deformity correction, and degenerative joint conditions. Orthopedic implants remain the primary treatment option for surgical management of foot and ankle conditions, including trauma fixation, joint reconstruction, and deformity correction. Rising incidences of lower extremity fractures, diabetes-related foot complications, age-related musculoskeletal degeneration, and sports injuries are driving demand globally.

The ambulatory surgical centers (ASCs) segment was valued at USD 1.3 billion in 2025 and is expected to grow at a CAGR of 6.7% during 2026-2035. ASCs are benefiting from the global shift toward outpatient orthopedic surgeries and minimally invasive procedures. Technological advancements in anesthesia, pain management, and surgical instrumentation have enabled ASCs to perform procedures such as bunion corrections, ligament reconstructions, and fixation surgeries safely in outpatient settings, supporting market growth.

U.S. Foot and Ankle Devices Market was valued at USD 2.6 billion in 2025. Growth is supported by the development of patient-specific implants, well-established healthcare infrastructure, high procedure volumes, comprehensive reimbursement frameworks, robust R&D activities, and accessible orthopedic specialists. The U.S. is also a leader in innovation, with new technologies such as total ankle replacement systems, advanced fixation screws, synthetic cartilage implants, and external fixation frames often launched and clinically validated domestically before global commercialization.

Prominent companies in the Global Foot and Ankle Devices Market include Acumed LLC, Embla Medical Corporation, Enovis Corporation, Arthrex, Inc., Medartis, Smith & Nephew plc, Stryker Corporation, VILEX, LLC, Zimmer Biomet Holdings, Inc., DePuy Synthes (Johnson & Johnson), CONMED Corporation, Ottobock SE & Co KGaA, Fillauer LLC, and aap implantate AG. Companies in the Global Foot and Ankle Devices Market strengthen their position by investing heavily in R&D for patient-specific implants, advanced fixation systems, and minimally invasive solutions. They pursue strategic partnerships with hospitals, surgical centers, and orthopedic clinics to integrate their devices into standard care pathways. Expanding geographically into emerging markets helps tap into growing patient populations. Firms also focus on product differentiation through innovative materials, 3D printing, and smart implant technologies. Comprehensive after-sales support, physician training programs, and collaborations with research institutions further solidify their market presence and enhance brand credibility.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product trends
    • 2.2.3 Application trends
    • 2.2.4 End use trends
  • 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of orthopedic disorders
      • 3.2.1.2 Rising incidence of trauma and road accidents
      • 3.2.1.3 Technological advancements in foot and ankle devices
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of foot and ankle devices
      • 3.2.2.2 Dearth of skilled healthcare professionals
    • 3.2.3 Opportunities
      • 3.2.3.1 Integration of digital health and smart orthotics
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
      • 3.4.1.1 U.S.
      • 3.4.1.2 Canada
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology and innovation landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Future market trends
  • 3.7 Reimbursement scenario
    • 3.7.1 North America
    • 3.7.2 Europe
    • 3.7.3 Asia Pacific
  • 3.8 Consumer behavior analysis
  • 3.9 Ring fixator competitive mapping, by company
  • 3.10 Hexapod categories and technology differentiation
  • 3.11 Price trends, by products
  • 3.12 Gap analysis
  • 3.13 Porter's analysis
  • 3.14 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
    • 4.1.1 Stryker Corporation
    • 4.1.2 DePuy Synthes (Johnson & Johnson)
    • 4.1.3 Arthrex Inc.
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Orthopedic implants and devices
    • 5.2.1 Joint implants
      • 5.2.1.1 Ankle implants
      • 5.2.1.2 Other joint implants
    • 5.2.2 Fixation devices
      • 5.2.2.1 Internal fixation devices
        • 5.2.2.1.1 Plates
        • 5.2.2.1.2 Screws
        • 5.2.2.1.3 Fusion nails
        • 5.2.2.1.4 Other internal fixation devices
      • 5.2.2.2 External fixation devices
        • 5.2.2.2.1 Ring fixation systems
        • 5.2.2.2.2 Pin-to-bar systems
        • 5.2.2.2.3 Hexapod systems
        • 5.2.2.2.4 Other external fixators
    • 5.2.3 Soft tissue orthopedic devices
  • 5.3 Bracing and support devices
    • 5.3.1 Soft bracing & support devices
    • 5.3.2 Hard braces & support devices
    • 5.3.3 Hinged braces & support devices
  • 5.4 Prostheses

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Trauma
  • 6.3 Hammertoe
  • 6.4 Osteoarthritis
  • 6.5 Rheumatoid Arthritis
  • 6.6 Neurological Disorders
  • 6.7 Osteoporosis
  • 6.8 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Orthopedic clinics
  • 7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 MEA
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 aap implantate AG
  • 9.2 Acumed LLC
  • 9.3 Arthrex, Inc.
  • 9.4 CONMED Corporation
  • 9.5 DePuy Synthes (Johnson & Johnson)
  • 9.6 Embla Medical Corporation
  • 9.7 Enovis Corporation
  • 9.8 Fillauer LLC
  • 9.9 Medartis
  • 9.10 Orthofix Medical Inc.
  • 9.11 Ottobock SE & Co KGaA
  • 9.12 Smith & Nephew plc
  • 9.13 Stryker Corporation
  • 9.14 VILEX, LLC
  • 9.15 Zimmer Biomet Holdings, Inc.